Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic meropenem in severe acute necrotizing pancreatitis
2004-000795-14Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in necrotizing pancreatitis (ANP) comparing Meropenem prophylaxis with Placebo (2 arms). Primary endpoint: Development of pancreatic or peripancreatic infection. Started Aug 2004; status: completed.
02
Drugs
meropenem
03
Conditions
necrotizing pancreatitis (ANP)
Beyond the preview
Go deeper on 2004-000795-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000795-14.